⚠ Official Notice: www.ijisrt.com is the official website of the International Journal of Innovative Science and Research Technology (IJISRT) Journal for research paper submission and publication. Please beware of fake or duplicate websites using the IJISRT name.



Pharmacognostic, Phytochemical, GC-MS and In silico Pharmacological Evaluation of Cleome gynandra L. Flowers


Authors : Gowthaman P.; Dr. R. Thiruvenkatasubramaniam; Dr. B. Sangameswaran

Volume/Issue : Volume 11 - 2026, Issue 9 - September


Google Scholar : https://tinyurl.com/2w2z989f

DOI : https://doi.org/10.38124/ijisrt/26sep1054

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : The present study was undertaken to investigate the pharmacognostic, physicochemical, phytochemical, GC–MS and in-silico pharmacological profiles of Cleome gynandra L. flowers. The flowers were authenticated and subjected to macroscopic and powder microscopic evaluation, which revealed characteristic diagnostic features including tetramerous flowers, prominent stamens, multicellular trichomes, anther tissues, xylem vessels, astrosclereids, calcium oxalate crystals, pollen grains and oil droplets. Physicochemical evaluation revealed acceptable ash, moisture, foaming, and extractive values. These parameters support the suitability of the flowers for quality assessment and standardization. Successive Soxhlet extraction with solvents of increasing polarity showed a comparatively higher extractive response with polar solvents, suggesting the predominance of polar and water-soluble constituents. Preliminary phytochemical screening revealed the presence of diverse classes of primary and secondary metabolites, including alkaloids, glycosides, flavonoids, tannins, carbohydrates and proteins, with variations observed among the different extracts. GC–MS analysis of the aqueous extract identified Stigmasterol, β-sitosterol and a Lupeol derivative, which were selected for further in-silico studies. ADME profiling provided preliminary information on their drug-likeness and pharmacokinetic properties. Molecular docking against antioxidant-related targets, NOX (PDB: 2CDU) and SOD1 (PDB: 2C9V), showed favourable predicted binding interactions, with Lupeol showing the strongest predicted affinity. Similarly, docking against antidiabetic related targets, α amylase (PDB: 1OSE) and α-glucosidase (PDB: 1UOK) demonstrated favourable interactions, particularly for Lupeol and β-sitosterol. Overall, Lupeol emerged as the most promising candidate among the investigated phytoconstituents. These findings provide preliminary In-silico evidence supporting the potential pharmacological relevance of Cleome gynandra L. flowers and warrant further experimental validation through in in-vitro and in-vivo Studies.

Keywords : Cleome gynandra L. Pharmacognosy, Phytochemistry, GC-MS, In-silico Pharmacology, Molecular Docking.

References :

  1. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 55th ed. Pune: Nirali Prakashan; 2008. p.1.11.
  2. Kar A. Textbook of Pharmacognosy and Phytochemistry-1. Delhi: Ahuja Book House Pvt Ltd; p.36-38.
  3. Arumugam KR, Murugesh N. Textbook of Pharmacognosy. 7th ed. 2004. p.21-23.
  4. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proceedings of the National Academy of Sciences. 1993;90:7915-7922.
  5. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 3rd ed. Oxford University Press; 1999.
  6. Droge W. Free radicals in the physiological control of cell function. Physiological Reviews. 2002;82:47-95.
  7. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Molecular Cell Biochemistry. 2004;266:37-56.
  8. Pisochi AM, Negulescu GP. Methods for total antioxidants activity determination: A review. Biochemistry and Analytical Biochemistry. 2011;1:1-10.
  9. Prior RL, Wu X, Schaich K. Standardized methods for the determination of antioxidant capacity and phenolics of foods and dietary supplements. Journal of Agricultural and Food Chemistry. 2005;53:4290-4302.
  10. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiological Reviews. 2007;87:315-424.
  11. Chan CH, Ngoh GC, Yusoff R. A brief review on anti-diabetic plants: Global distribution, active ingredients, extraction techniques and acting mechanisms. 2012. doi:10.4103/0973-7847.95854.
  12. Jung M, Park M, Lee HC, Kang YH, Kang ES, Kim SK. Antidiabetic Agents from Medicinal Plants. 2006.
  13. Patel DK, Kumar R, Laloo D, Hemalatha S. Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity. Asian Pacific Journal of Tropical Biomedicine. 2012;2(5):411-420.
  14. Ekins S, Mestres J, et al. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. British Journal of Pharmacology. 2007;152(1).
  15. Poudyl B, et al. Molecular Docking technique. National Journal of Pharmaceutical Sciences. 2021;1(1):08-14.
  16. Tiwari S, Prakash K, et al. Unrevealing the complex interplay: molecular docking: A comprehensive review on current scenario, upcoming difficulties, forthcoming initiatives and viewpoints. International Journal of Chemistry Research. 2023;8(1):1-9.
  17. Shanmugam S, Rajendran K, Suresh B. Medicinally Important Plant Cleome gynandra L.: A Phytochemical and Pharmacological Review. Research Journal of Pharmacy and Technology. 2013;6(8):859-863.
  18. Mishra SS, Moharana SK, Dash MR. Review on Cleome gynandra L. International Journal of Research in Pharmacy and Chemistry. 2011;1(3):681-689.
  19. Bhattacharya S, Singh S, Kumar A. A Comprehensive Study on the Occurrence Records of the African Neglected and Underutilized Weed Species Cleome gynandra L. (cat's whiskers): validating the Eco geographical range expansion in West Bengal, India. NeBIO. 2019;10(1):1-7.
  20. Debnath A, Paul C, Debnath B. Eight new additions of plant species to the flora of foot Himalayan state Tripura, North East India: distributional range extension, geographic map, and their less-known ethnomedicines. NeBIO. 2017;8(4):1-8.
  21. Mishra SS, Moharana SK, Dash MR. Review on Cleome gynandra L. International Journal of Research in Pharmacy and Chemistry. 2018;8(2):1-8.
  22. Anbazhagi K, Kadavul G, Suguna L, Petrus AJA. Studies on the pharmacognostical and in vitro antioxidant potential of Cleome gynandra Linn. Leaves. Natural Product Radiance. 2009;8(2):151-157.
  23. Shilla O, Dinssa FF, Omondi EO, Winkelmann T, Abukutsa-Onyango MO. Cleome gynandra L. origin, taxonomy and morphology: A review. African Journal of Agricultural Research. 2019;14(32):1568-1583.
  24. Chweya JA, Mnzava NA. Cleome gynandra L.: Promoting the conservation and use of underutilized crops. IPGRI, Rome; 1997.
  25. The Ayurvedic Pharmacopoeia of India. Part I, Volume I. Ministry of Health and Family Welfare, Government of India; 1989.
  26. Saravanan R, Natesan R, Ramalingam S. Pharmacognostic Profiling of Cleome gynandra L.—A Traditional Folk Medicine. JPNR. 2022;3746-3753.
  27. Adhikari PP, Paul SB. Medicinally important plant Cleome gynandra: a phytochemical and pharmacological explanation. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(1):21-29.
  28. Khuntia A, Martorell M, Ilango K, Bungau SG, Radu AF, Behl T, Sharifi-Rad J. Theoretical evaluation of Cleome species' bioactive compounds and therapeutic potential: A literature review. Biomedicine & Pharmacotherapy. 2022;151:113161.
  29. Narendhirakannan RT, Kandaswamy M, Subramanian S. Anti-inflammatory activity of Cleome gynandra L. on hematological and cellular constituents in adjuvant-induced arthritic rats. Indian J Med Food. 2005;8(1):93-99.
  30. Narendhirakannan RT, Subramanian S, Kandaswamy M. Anti-inflammatory and lysosomal stability actions of Cleome gynandra L. studied in adjuvant induced arthritic rats. Food and Chemical Toxicology. 2007;45(6):1001-1012.
  31. Sowunmi LI, Afolayan AJ. Phytochemical constituents and antioxidant properties of acetone extract of Cleome gynandra (L.) growing in the Eastern Cape, South Africa. African Journal of Traditional, Complementary and Alternative Medicines. 2015;12(3):1-8.
  32. Pandey KB, Rizvi SI. Plant polyphenols dietary antioxidants in human health and disease. Indian Journal of Clinical Biochemistry. 2009;24(3):270-278.
  33. Ravichandra B, Ram PS, Saritha C, Shankaraiah P. Anti diabetic and anti-dyslipidemia activities of Cleome gynandra in alloxan induced diabetic rats.
  34. Choudhury S, Sharan RN, Khanna VK. Phytochemicals with anti-hyperglycemic activity: Evidence from Indian medicinal plants. Indian Journal of Natural Products and Resources. 2012;3(2):145-152.
  35. Sivakumar KK, Rajasekaran A, Ponnilavarasan I, Somasundaram A, Sivasakthi R. Antiulcer and analgesic activity of the ethanol extract of Cleome gynandra Linn leaves. Research Journal of Pharmacy and Technology. 2010;3(3):766-769.
  36. Imanirampa L, Alele PE. Antifungal activity of Cleome gynandra L. aerial parts for topical treatment of Tinea capitis: an in-vitro evaluation. BMC Complementary and Alternative Medicine. 2016;16:1-8.
  37. Narendhirakannan RT, Subramanian S, Kandaswamy M. Antifungal potential of phytochemical-rich extracts of Cleome gynandra L. against pathogenic fungi. Indian Journal of Experimental Biology. 2005;43(9):789-793.
  38. Sridhar N, Kiran BV, Sasidhar DT, Kanthal LK. In-vitro antimicrobial screening of methanolic extracts of Cleome chelidonii and Cleome gynandra. Bangladesh Journal of Pharmacology. 2014;9(2):161-166.
  39. Abeysinghe Pushpa D, Weeraddana Chaminda De S. Screening of Petroleum ether, Chloroform, Ethyl acetate, Ethanol and Water Extracts of Medicinal Plant, Avicennia marina for Antibacterial Activity against Antibiotic Resistant Bacteria Species, Staphylococcus and Proteus. JPBMS. 2011-11(18).
  40. Shaikh JR, Patil MK. Qualitative tests for preliminary phytochemical screening: An overview. International Journal of Chemical Studies. 2020;8(2):603-608.
  41. Sathe KP, et al. A review on Gas Chromatography-Mass Spectrometry (GC-MS). World Journal of Pharmaceutical Research. 2021;10(3):741-763.
  42. Mhya DH, Jakwa AG, Agbo J. In Silico Analysis of Antioxidant Phytochemicals with Potential NADPH Oxidase Inhibitory Effect. Journal of Health Science and Medical Research. 2023;41(2):e2022912.
  43. Bhatia NK, Modi P, Sharma S, Deep S. Quercetin and Baicalein Act as Potent Antiamyloidogenic and Fibril Destabilizing Agents for SOD1 Fibrils. ACS Chemical Neuroscience. 2020;11(8):1129-1138.
  44. Lenh Vo Van, Pham EC, Nguyen CV, Nguyen NT, Le TVT, Truong TN. In vitro and in vivo antidiabetic activity, isolation of flavonoids, and in silico molecular docking of stem extract of Merremia tridentata (L.). Biomedicine & Pharmacotherapy. 2022;146: 112611.

The present study was undertaken to investigate the pharmacognostic, physicochemical, phytochemical, GC–MS and in-silico pharmacological profiles of Cleome gynandra L. flowers. The flowers were authenticated and subjected to macroscopic and powder microscopic evaluation, which revealed characteristic diagnostic features including tetramerous flowers, prominent stamens, multicellular trichomes, anther tissues, xylem vessels, astrosclereids, calcium oxalate crystals, pollen grains and oil droplets. Physicochemical evaluation revealed acceptable ash, moisture, foaming, and extractive values. These parameters support the suitability of the flowers for quality assessment and standardization. Successive Soxhlet extraction with solvents of increasing polarity showed a comparatively higher extractive response with polar solvents, suggesting the predominance of polar and water-soluble constituents. Preliminary phytochemical screening revealed the presence of diverse classes of primary and secondary metabolites, including alkaloids, glycosides, flavonoids, tannins, carbohydrates and proteins, with variations observed among the different extracts. GC–MS analysis of the aqueous extract identified Stigmasterol, β-sitosterol and a Lupeol derivative, which were selected for further in-silico studies. ADME profiling provided preliminary information on their drug-likeness and pharmacokinetic properties. Molecular docking against antioxidant-related targets, NOX (PDB: 2CDU) and SOD1 (PDB: 2C9V), showed favourable predicted binding interactions, with Lupeol showing the strongest predicted affinity. Similarly, docking against antidiabetic related targets, α amylase (PDB: 1OSE) and α-glucosidase (PDB: 1UOK) demonstrated favourable interactions, particularly for Lupeol and β-sitosterol. Overall, Lupeol emerged as the most promising candidate among the investigated phytoconstituents. These findings provide preliminary In-silico evidence supporting the potential pharmacological relevance of Cleome gynandra L. flowers and warrant further experimental validation through in in-vitro and in-vivo Studies.

Keywords : Cleome gynandra L. Pharmacognosy, Phytochemistry, GC-MS, In-silico Pharmacology, Molecular Docking.

Paper Submission Last Date
31 - October - 2026

SUBMIT YOUR PAPER CALL FOR PAPERS
Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe